K012131Substantially Equivalent
Livesure Benzodiazepines Screen Tests
Pan Probe Biotech, Inc., San Diego CA / Traditional, Substantially Equivalent
K012131 is the FDA 510(k) clearance record for LIVESURE BENZODIAZEPINES SCREEN TESTS, a class II device, cleared for Pan Probe Biotech, Inc. on under FDA product code JXM (Enzyme Immunoassay, Benzodiazepine). FDA records list 10 510(k) clearances for Pan Probe Biotech, Inc., from to . As of , FDA records show no recalls naming K012131.
Clearance record
- Decision date
- Received
- (11 days to decision)
- Product code
- JXM Enzyme Immunoassay, Benzodiazepine
- Regulation
- 21 CFR 862.3170
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Applicant
- Pan Probe Biotech, Inc. 8515 Arjons Dr., Suite A, San Diego CA
- 510(k) summary
- Summary
- Third party review
- Yes
Clearances, product code JXM
Trailing 12 monthsFDA records hold no clearances under product code JXM in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
